{"id":915090,"date":"2026-07-05T22:58:15","date_gmt":"2026-07-05T22:58:15","guid":{"rendered":"https:\/\/www.europesays.com\/us\/915090\/"},"modified":"2026-07-05T22:58:15","modified_gmt":"2026-07-05T22:58:15","slug":"surprising-possible-benefit-for-ladies-on-weight-loss-meds","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/915090\/","title":{"rendered":"Surprising Possible Benefit for Ladies on Weight Loss Meds"},"content":{"rendered":"<p class=\"storyParagraph\">&#13;<br \/>\n                                        A new working paper suggests that the power of popular weight-loss drugs may extend to the job market. In a report published by the <a href=\"https:\/\/www.nber.org\/papers\/w35387?utm_campaign=ntwh&amp;utm_medium=email&amp;utm_source=ntwg18\" rel=\"nofollow noopener\" target=\"_blank\">National Bureau of Economic Research<\/a>, Harvard economist Rebecca Diamond analyzed survey data from more than 10,000 adults and found that unemployed women who started taking GLP-1 medications such as Ozempic and Wegovy saw their employment rate rise 27% after 18 months, compared with similar women who wanted the drugs but hadn&#8217;t yet used them, reports <a href=\"https:\/\/www.fastcompany.com\/91567543\/study-women-are-more-likely-to-get-hired-after-taking-glp-1s\" rel=\"nofollow noopener\" target=\"_blank\">Fast Company<\/a>. Diamond says the effects seem tied to first impressions, not career progression: Women already employed saw little change in pay or job mobility due to their GLP-1 use.&#13;\n                                    <\/p>\n<p class=\"storyParagraph\">&#13;<br \/>\n                                        The pattern extended to dating, with single women 29% more likely to marry or move in with a partner within 18 months after beginning to take the meds. The &#8220;depressing&#8221; study, which <a href=\"https:\/\/www.businessinsider.com\/ozempic-glp-1-weight-loss-women-jobs-marriage-harvard-study-2026-6\" rel=\"nofollow noopener\" target=\"_blank\">Business Insider<\/a> reports hasn&#8217;t yet been peer reviewed, underscores long-standing evidence that weight bias shapes hiring\u2014and raises questions about how access to GLP-1s could deepen workplace inequality. &#8220;Wealthier women who can afford GLP-1s out of pocket could stand to become wealthier in the labor and marriage markets (which have financial benefits),&#8221; the outlet notes.&#13;\n                                    <\/p>\n","protected":false},"excerpt":{"rendered":"&#13; A new working paper suggests that the power of popular weight-loss drugs may extend to the job&hellip;\n","protected":false},"author":3,"featured_media":915091,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[34],"tags":[25055,263,3654,210,7414,1060,427,7572,67,132,68,2402,428,16966,286005],"class_list":["post-915090","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-discoveries","tag-employment","tag-glp-1","tag-health","tag-hiring","tag-medication","tag-ozempic","tag-study","tag-united-states","tag-unitedstates","tag-us","tag-wegovy","tag-weight-loss","tag-women","tag-workplace-discrimination"],"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/915090","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=915090"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/915090\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/915091"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=915090"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=915090"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=915090"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}